Supported by an educational grant from NPS Pharmaceuticals, Inc.
Upon completion of this educational activity, participants will be better able to:
- Apply new insights on the epidemiology and symptom burden of hypoparathyroidism to the proactive screening of at-risk patients and early recognition of hypoparathyroidism
- Implement a strategy to prevent, detect, and manage the potential adverse effects of long-term calcium and vitamin D therapy in patients with hypoparathyroidism
- Evaluate the role of PTH replacement therapy in the management of hypoparathyroidism based on recent clinical-trial findings and expert guidance
There is no cost to attend, however, seating is limited. Complimentary breakfast or dinner will be provided and all ENDO attendees are welcome. Priority seating will be given to Registration Ticket holders for the first 15 minutes after the advertised start time. If you have not been able to secure a Registration Ticket, the Endocrine Society will have a non-Ticket holder line for general admission to the session on a first-come, first-served basis. Register Now.